Biocrates Life Sciences

OverviewSuggest Edit

Biocrates Life Sciences is a developer of targeted metabolic phenotyping solutions. It discovers and validates biomarkers for complex multifactorial diseases in pre-clinical and clinical research. The company offers the possibility to identify potential biomarkers for diagnostic investigation as well as drug therapy monitoring.
TypePrivate
Founded2002
HQInnsbruck, AT
Websitebiocrates.com

Recent NewsAll News

Latest Updates

Employees (est.) (Nov 2020)54(+2%)
Cybersecurity ratingCMore

Key People/Management at Biocrates Life Sciences

Moritz Seuster

Moritz Seuster

Co-Chief Executive Officer, Chief Financial Officer
Matthias Scheffler

Matthias Scheffler

Chief Business Officer
Nicolas Schauer

Nicolas Schauer

Co-Chief Executive Officer, Chief Scientific Officer
Therese Koal

Therese Koal

Chief Technology Officer
Show more

Biocrates Life Sciences Office Locations

Biocrates Life Sciences has an office in Innsbruck
Innsbruck, AT (HQ)
Eduard-Bodem-Gasse 8
Show all (1)

Biocrates Life Sciences Financials and Metrics

Summary Metrics

Founding Date

2002

Biocrates Life Sciences total Funding

$14.2 m

Biocrates Life Sciences latest funding size

$955.97 k

Time since last funding

5 years ago

Biocrates Life Sciences investors

Biocrates Life Sciences's latest funding round in December 2015 was reported to be $956 k. In total, Biocrates Life Sciences has raised $14.2 m
Show all financial metrics

Biocrates Life Sciences Cybersecurity Score

Cybersecurity ratingPremium dataset

C

74/100

SecurityScorecard logo

Biocrates Life Sciences Online and Social Media Presence

Embed Graph

Biocrates Life Sciences Blogs

Metabolite of the month – Kynurenine

The metabolite of this month focuses on kynurenine, a tryptophan-derived metabolite at the crossroads between neurology, immunology and cancer.

Machine learning for ALS progression biomarker discovery

How to combine targeted metabolomics and machine learning algorithms to identify biomarkers associated with ALS disease progression.

Bile acids and newborn’s gut microbiota maturation

The maturation of the newborn´s microbiome is critically dependent on bile acids from liver and can be manipulated by administration of bile acids in mice.

Circulating metabolites predict coronary heart disease risk

Serum metabolites were associated with risk of coronary heart disease in a population-based cohort, with a comparable strength to classic risk factors.

Biocrates Life Sciences Frequently Asked Questions

  • When was Biocrates Life Sciences founded?

    Biocrates Life Sciences was founded in 2002.

  • Who are Biocrates Life Sciences key executives?

    Biocrates Life Sciences's key executives are Moritz Seuster, Matthias Scheffler and Nicolas Schauer.

  • How many employees does Biocrates Life Sciences have?

    Biocrates Life Sciences has 54 employees.

  • Who are Biocrates Life Sciences competitors?

    Competitors of Biocrates Life Sciences include Universal Biosensors, Castle Biosciences and Laboratory Corporation of America Holdings.

  • Where is Biocrates Life Sciences headquarters?

    Biocrates Life Sciences headquarters is located at Eduard-Bodem-Gasse 8, Innsbruck.

  • Where are Biocrates Life Sciences offices?

    Biocrates Life Sciences has an office in Innsbruck.

  • How many offices does Biocrates Life Sciences have?

    Biocrates Life Sciences has 1 office.